Home

Rita Jain

CIK 1707797 · EVP, Chief Medical Officer · last filed 2026-07-02

Rita Jain is an EVP, Chief Medical Officer who has filed 42 SEC Form 4 insider transactions across 9 companies since 2017. The most recent filing, for AVTX, was dated Jul 2, 2026. Current disclosed insider exposure totals $6.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$6.12M

Companies

9

Total Filings

42

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AVTX Director — $19.52 — $0 6 2026-07-02
CLDX Director — $35.58 — $0 4 2026-06-29
TRAX Director 19,194 $41.85 $803.3K $0 4 2026-06-17
ANAB Director 11,864 $52.11 $618.2K $0 6 2026-01-08
SABSW Director — $0.01 — $0 1 2026-01-07
Provention Bio, Inc. (PRVB) Delisted Director — $24.98 — $0 2 2023-04-27
CCXI EVP, Chief Medical Officer 0 $14.52 $0 $0 11 2022-10-24
IMVT Chief Medical Officer 117,600 $38.90 $4.57M $0 3 2021-03-31
AKBA SVP, Chief Medical Officer 96,332 $1.27 $122.3K $0 5 2019-04-12

Recent Filings

42 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-02 AVTX Grant (A) — $0 EDGAR
2026-06-29 CLDX Grant (A) — $0 EDGAR
2026-06-17 TRAX Exer (M) +7,330 $0 EDGAR
2026-06-12 TRAX Grant (A) — $0 EDGAR
2026-06-04 AVTX Grant (A) — $0 EDGAR
2026-05-14 TRAX Grant (A) — $0 EDGAR
2026-04-22 TRAX Grant (A) — $0 EDGAR
2026-04-01 AVTX Grant (A) — $0 EDGAR
2026-01-08 ANAB Grant (A) — $0 EDGAR
2026-01-07 SABSW Grant (A) — $0 EDGAR
Showing 1–10 of 42
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.